0.4881  0.016 (3.3%)		08-07 14:45
Open: 0.461 High: 0.5 Volume: 43,242		Pre. Close: 0.4725 Low: 0.4575 Market Cap: 15(M)

Short term
Mid term
Targets	6-month :	0.67	1-year :	0.77
Resists	First :	0.57	Second :	0.66
Pivot price	0.51
Supports	First :	0.44	Second :	0.37
MAs	MA(5) :	0.48	MA(20) :	0.52
	MA(100) :	0.48	MA(250) :	0.75
MACD	MACD :	-0.1	Signal :	0
%K %D	K(14,3) :	27	D(3) :	26.1
RSI	RSI(14): 44.2
52-week	High :	1.55	Low :	0.3

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ONMD ] has closed above bottom band by 22.0%. Bollinger Bands are 30.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.51 - 0.51	0.51 - 0.51
Low:	0.47 - 0.47	0.47 - 0.47
Close:	0.49 - 0.49	0.49 - 0.49

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.

Thu, 07 Aug 2025
OneMedNet announces greater than 25% expansion of iRWD network, platform - TipRanks

Mon, 04 Aug 2025
OneMedNet expands RWD network by 25%, adding 5 billion records. - AInvest

Mon, 04 Aug 2025
OneMedNet Reports Over 25% Expansion of iRWD™ Network, - GlobeNewswire

Mon, 04 Aug 2025
OneMedNet's Massive Healthcare Data Expansion: 5 Billion New Records Power AI-Driven Clinical Insights - Stock Titan

Thu, 31 Jul 2025
OneMedNet stock rises after partnership with Inka Health for cancer trials - Investing.com

Wed, 25 Jun 2025
OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting Strategic Progress - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	0 (M)
Shares Float	46 (M)
Held by Insiders	1.254e+007 (%)
Held by Institutions	59.6 (%)
Shares Short	87 (K)
Shares Short P.Month	0 (K)

EPS	-9.67e+006
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	623.3 %
Return on Equity (ttm)	-490 %
Qtrly Rev. Growth	532000 %
Gross Profit (p.s.)	-49.78
Sales Per Share	0
EBITDA (p.s.)	-484444
Qtrly Earnings Growth	-0.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-7 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-0.79

Dividend	0
Forward Dividend	1.21e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.